Medical Consequences of Stopping Anticoagulant Therapy Before Intraocular Surgery or Intravitreal Injections
Authors:
- 1 September 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Retina
- Vol. 27 (7) , 813-815
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- ANTICOAGULATION WITH WARFARIN IN VITREORETINAL SURGERYRetina, 2007
- Maintenance of Warfarin Anticoagulation for Patients Undergoing Vitreoretinal SurgeryArchives of Ophthalmology (1950), 2006
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgeryOphthalmology, 2003
- Prevalence of Age-related Maculopathy in AustraliaOphthalmology, 1995
- Management of the anticoagulated patient for ophthalmic surgeryEye, 1993
- Warfarin and cataract extraction.British Journal of Ophthalmology, 1989
- Anticoagulants and cataract surgeryJournal of Cataract & Refractive Surgery, 1988
- Intraocular lenses and anticoagulation and antiplatelet therapyAmerican Intra-Ocular Implant Society Journal, 1985